Engineering future people would be a disaster
By Stuart A. Newman and Tina Stevens,
Medium
| 08. 03. 2020
Modifying genes shows promise in curing medical conditions in sick people. Should it be used to make irreversible changes in people who don’t yet exist? Current research suggests that this would be a big mistake.
Studies in animals, including one described recently in Wired, show that the gene manipulation technique CRISPR has a habit of inserting bacterial DNA along with the desired sequences into various sites in chromosomes, with unknown consequences. Even more alarming was a news article last month in the scientific journal Nature that bore the title “CRISPR gene editing in human embryos wreaks chromosomal mayhem.” It reported results described in three preprints — ready-to-be-published studies — by several prominent investigators in the field that attempted to make specific, targeted changes in the embryos’ DNA, the sort of alterations that might be tried to prevent a newborn from inheriting a gene associated with a disabling condition. There was no intention by the scientists to bring these embryos to birth. They were just being used experimentally to see if the technique worked. It didn’t.
Thus, even if the modification method were perfect, the variability of human biology means that we won’t know what the outcome will be. The new results, however, cast strong doubt on the CRISPR technique itself. In the words of...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...